Diagnostic testing company LumiraDx and CA Healthcare Acquisition completed their merger. LumiraDx shares begin trading today on the Nasdaq under LMDX. Warrants list under LMDXW.
There was no mention of redemptions, if any, in the companies’ news release, although CA Healthcare consistently traded above the $10 redemption danger zone in the period leading up to the vote.
The company listed at a valuation of $3 billion. Read more.
